your attention to a press denial by the trustees that the centre is to close. This is a decision which still has to be discussed by the trustees in the light of the resignation of Dr. Shaldon, which is to take effect from 1 July 1968. Obviously, if a suitable replacement for Dr. Shaldon could be found within a reasonable period of time the centre could continue to function, but if perchance this is not possible inevitably and regretfully it would have to close.
On 9 May last a meeting took place with representatives of the Minister of Health to discuss a Ministry of Health circular, No. H/A 190/14, where the Minister advised chairmen of medical committees of teaching hospitals and senior administrative officers that, while regional hospital boards have the power to refer patients to the National Kidney Centre and pay for treatment outside the N.H.S., it was the unanimous recommendation of the meeting that patients should not be referred, as this form of treatment should be based only on hospitals with full supporting facilities. At this meeting a plan to provide chronic dialysis in the United Kingdom based on the use of home haemodialysis, which would integrate the National Kidney Centre within the National Health Service, thereby making all the medical equipment and financial resources available to the National Health Service, was submitted for consideration, and to date no reply to this olan has been received.
The attitude of the trustees of the National Kidney Centre and its medical director has always been an unselfish one, and the result of Dr. Shaldon's research into home dialysis was quite staggering in its potential in the terms of numbers which could be treated. We therefore feel that by integration with the N.H.S. the maximum number of people suffering from this disease in the United Kingdom could receive benefit.
Regretfully, it is the complete lack of interest and approach to this matter which has developed cumulative frustration in our medical director which now results in his resignation. I would have thought that from a national point of view there must be a strong case for the retention of the National Kidney Centre until such time as a better form of development could be substituted in its place. Should the train of events now result in the eventual closure of the National Kidney Centre it would be a national tragedy.
The result during the last seven weeks has already proved disastrous, as the programme of the centre was to accept 60 patients by the end of the year. During the past three weeks any patients referred have not been accepted. By the end of the year, if the situation continues, some 30 prospective patients will die needlessly.
The National Kidney Centre has been established as a charitable, non-profit-making organization to provide artificial kidney treatment to as many patients as possible. The centre is concerned with providing treatment under ideal circumstances-one unit, one patient, at home and freed from the need for repeated hospital attendance, involving travel and pressure on bed space and nursing staff in the already overburdened Health Service hospitals. Though the effectiveness of artificial kidney treatment for those with incurably diseased or damaged kidneys is medically accepted beyond dispute, the National Health Service will be unable to provide this form of treatment for more than 5 to 10% of those who could benefit in the next few years. This means that 5,000 to 10,000 sufferers in this country will die unnecessarily in that time.
The These figures demonstrate the efficiency of the helmet in protecting th: top of the head. Unfortunately, the design and wearing fashion of the helmet did not give the same degree of protection to the front of the head in Correspondence underground workers. The helmet will only protect the head from injury if it is worn correctly and is designed to prevent those injuries which are foreseen. It must always be regarded as a second line of defence; accident prevention must be the primary aim.
Mr. Jennett is in error when he states that V. S. Caviness's conclusions' were based solely on a study of first world war gunshot wounds. In the statement I quoted from reference was made to the work of W. F. Caveness,' who investigated 356 young adult males who sustained head injuries in the Korean war campaign. Of these, 159 had non-missile head injuries. The report deals with the occurrence of epileptic attacks in the first 8 to 11 years following head injuries. W. F. Caveness stated, "While mode of injury is an important factor in the onset of fits, there is no significant difference between missile-and non-missile-injured men as regards the cessation of fits. A common clinical impression has been that the earlier the fits take place the less likely are they to persist. This has been held especially for those fits that occur within a few hours or days after injury. Conversely, it has been thought that those attacks that begin after one year seldom cease. In the current series neither is borne I share their view that the outcome of surgical treatment of hypertension may be unpredictable or disappointing-but I repeat the comment that the value of aortography should not be judged on this alone. If the procedure adds to the diagnostic data and enables one to exclude certain disorders (for example, fibromuscular dysplasia) and assists in obtaining a likely explanation for the hypertension (for example, "essential hypertension" with renal arterial anomalies) then there has been a useful gain. Further, I believe that medical management may be influenced in a number of ways by the aortographic findings-if only in providing a oncein-a-lifetime survey of the renal and intraabdominal vascular tree and relieving the physician of the misgiving that he may be overlooking some important disorder. I have seen the sad consequences of inadequate investigation too often to feel confident in advising my patients after incomplete assessment.
Drs. Chamberlain and Gleeson chose to quote only our first and smaller series' in an implicadon that our series was somewhat unrepresentative (with a 9-to-1 male to female ratio, and two-thirds of the patients being Service personnel). The second paper which they mentioned4 but did not quote in this context studies almost three times as many patients (341 as against 121), and 1 in 4 of the patients was female. As a matter of fact over the eight years which our unit has been working the proportion of Service to civilian patients is almost exactly 50%.
Their own work presented an interesting analysis of a retrospective study on a relatively small number of aortograms. We were not told of the period of time from which these results were collected, nor from how many hypertensive patients their 107 cases wzr: selected-nor indeed how they were selected. Presumably since their text states "records of all aortograms were available and through these a retro. spective study . . . was possible," the figure of 107 represents all patients subected to angiography for hypertension at the Westminster Hospital since angiography was first introduced.
It would be unusual if there had not been many hundreds, if not thousands, of hypertensive patients attending for advice, investigation, and treatment over this period-so my contient that their series was highly selected must stand. Whether our own papers described a selected series of patients is not relevant to the discussion on angiography, though it might be to any discussion on hypertension. Any series is in fact initially selected by geographical, environmental, and other features-but we did describe the findings from a large number of unselected angiograms (since all patients under investigation for hypertension were angiographed) in a prospective study. This seems to me a much more acceptable method of assessing the value of the procedure. Progestin Therapy of Breast Cancer SIR,-Dr. B. A. Stoll (5 August, p. 338) has to be congratulated for his very worthwhile attempt at screening the efficacy of various progestational preparations in the treatment of advanced breast cancer. The paucity of satisfactory responses in his series of seven compounds tested should not discourage the search for more effective agents. The smallest change in the chemical structure of these steroids can markedly alter their clinical efficacy. 'For'instance, the negative impression gained in the earliest trial in this country with norethisterone oenanthate was dispelled by a very similar compound having a shorter side chain and giving improved clinical results. Similarly the addition of 5 mg. oestradiol benzoate to progesterone 50 mg. by daily injection proved successful in 7 of the 15 cases with breast cancer treated by Landau et al.' In this department further experience was gained from the combination of progesterone (19-nor-177a-hydroxyprogesterone caproate) 100 mg., with oestradiol valerate, 30 mg. Twenty-five patients (four premenopausal) with advanced cancer of the breast in whom previous surgery, radiotherapy, oestrogens, and androgens have either failed to arrest the progress of the disease or ceased to be effective were treated with this compound for periods of one to 14 months, receiving intramuscular injections weekly, later increased to twice weekly. In 8 cases (32%) a moderate to good response was noted with regression of visible skin and glandular neoplastic infiltration, disappearance of oedema, and amelioration.,of..general conditions. In
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